Harel Insurance Investments & Financial Services Ltd. - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 28 filers reported holding VASCULAR BIOGENICS LTD in Q4 2021. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Harel Insurance Investments & Financial Services Ltd. ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q3 2023$30.0%11,0000.0%0.00%
Q2 2023$3
+50.0%
11,0000.0%0.00%
Q1 2023$2
+100.0%
11,0000.0%0.00%
Q4 2022$1
-100.0%
11,0000.0%0.00%
Q3 2022$2,000
-88.9%
11,0000.0%0.00%
Q2 2022$18,000
-5.3%
11,0000.0%0.00%
Q1 2022$19,000
-95.0%
11,000
-94.3%
0.00%
-100.0%
Q4 2021$382,000194,0000.01%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,593,286$5,751,0000.66%
Ikarian Capital, LLC 830,007$1,337,0000.24%
Telemetry Investments, L.L.C. 118,000$190,0000.22%
Urban Wealth Management, LLC 12,018$19,0000.06%
DLD Asset Management, LP 337,300$541,0000.04%
Phoenix Holdings Ltd. 513,597$827,0000.02%
Caption Management, LLC 140,000$225,0000.00%
HBK Sorce Advisory LLC 22,000$35,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 79,716$128,0000.00%
Total Clarity Wealth Management, Inc. 4,000$6,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders